Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Go back to Resources

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes.

Go back to Resources

Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

Go back to Resources

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Level of oral health impacts among patients participating in PEARL: a dental practice-based research network.

Go back to Resources

Level of oral health impacts among patients participating in PEARL: a dental practice-based research network.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Improvement in outcomes of clinical islet transplantation: 1999-2010.

Go back to Resources

Improvement in outcomes of clinical islet transplantation: 1999-2010.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Solid tumors following kidney transplantation in children.

Go back to Resources

Solid tumors following kidney transplantation in children.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females.

Go back to Resources

Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin.

Go back to Resources

Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries.

Go back to Resources

Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.

Go back to Resources

Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 67
  • Page 68
  • Page 69
  • Page 70
  • Current page 71
  • Page 72
  • Page 73
  • Page 74
  • Page 75
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification